- Home
- MUE vs SOPH Comparison
MUE vs SOPH Comparison
Compare MUE & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MUE
- SOPH
- Stock Information
- Founded
- MUE 1999
- SOPH 2011
- Country
- MUE United States
- SOPH Switzerland
- Employees
- MUE N/A
- SOPH N/A
- Industry
- MUE Investment Bankers/Brokers/Service
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MUE Finance
- SOPH Health Care
- Exchange
- MUE Nasdaq
- SOPH Nasdaq
- Market Cap
- MUE 208.4M
- SOPH 193.8M
- IPO Year
- MUE N/A
- SOPH 2021
- Fundamental
- Price
- MUE $9.53
- SOPH $3.04
- Analyst Decision
- MUE
- SOPH Strong Buy
- Analyst Count
- MUE 0
- SOPH 2
- Target Price
- MUE N/A
- SOPH $6.50
- AVG Volume (30 Days)
- MUE 62.6K
- SOPH 165.8K
- Earning Date
- MUE 01-01-0001
- SOPH 08-05-2025
- Dividend Yield
- MUE 4.09%
- SOPH N/A
- EPS Growth
- MUE N/A
- SOPH N/A
- EPS
- MUE N/A
- SOPH N/A
- Revenue
- MUE N/A
- SOPH $67,173,000.00
- Revenue This Year
- MUE N/A
- SOPH $16.07
- Revenue Next Year
- MUE N/A
- SOPH $22.94
- P/E Ratio
- MUE N/A
- SOPH N/A
- Revenue Growth
- MUE N/A
- SOPH 4.66
- 52 Week Low
- MUE $8.53
- SOPH $2.58
- 52 Week High
- MUE $10.17
- SOPH $4.92
- Technical
- Relative Strength Index (RSI)
- MUE 49.61
- SOPH 54.57
- Support Level
- MUE $9.40
- SOPH $3.01
- Resistance Level
- MUE $9.54
- SOPH $3.25
- Average True Range (ATR)
- MUE 0.07
- SOPH 0.23
- MACD
- MUE 0.01
- SOPH 0.02
- Stochastic Oscillator
- MUE 59.09
- SOPH 68.49
About MUE Blackrock MuniHoldings Quality Fund II Inc.
BlackRock MuniHoldings Quality Fund II Inc is a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. The fund seeks to achieve its investment objective by investing in long-term, investment-grade municipal obligations exempt from U.S. federal income taxes.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.